Monday 15 June 2026

One To Watch

Aphaia Pharma

Aphaia Pharma is a clinical-stage biopharmaceutical company with headquarters in Switzerland, Canada and Puerto Rico.

Company Overview

Want to Update your Company's Profile?


Latest Aphaia Pharma News

New approach to diabetes is effective in mid-stage trial
24 June 2024
More Aphaia Pharma news >


Today's issue

J&J’s Talvey combo cuts progression risk in earlier myeloma setting
Biotechnology
J&J’s Talvey combo cuts progression risk in earlier myeloma setting
15 June 2026
Pharmaceutical
Pharmstandard to build large-scale complex for production of live vaccines
15 June 2026
Biotechnology
Positive Phase III results for Intellia’s lonvo-z
15 June 2026
Biotechnology
FDA approves Keytruda-Welireg regimen for high-risk kidney cancer after surgery
15 June 2026
Pharmaceutical
Regulatory round-up: 15 June 2026
15 June 2026
Pharmaceutical
Zepzelca fails Phase III test in relapsed small-cell lung cancer
15 June 2026
Pharmaceutical
EFPIA says wider patent incentive could draw $52 billion to Europe
15 June 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze